Related research has unveiled that the transfection process of miR-339-5P mimics reduced the proliferative, migratory, invasive abilities, and other abilities of prostate carcinoma cells, increased apoptosis rate, increased E-cadherin in epithelial mesenchymal transformation, and decreased snell-2 and N-cadherin expression [21]. Here, CDH2 is linked to prostate carcinoma.